Details Of Published TSH Receptor Mutation

Back To All Mutations

Leu 267 Phe

c.808C>T

Constitutively Activating TSH Receptor Mutation

Type

gain

Manifestation

family

Exon

Nishihara et al.

Legend:

Male

Female

Unknown

Deceased

Mutation

No Mutation

Hyperthyroidism
(Heterozygous)

Goiter

Relapse

Index Patient

Molecular Characteristics:

No published data for in vitro characterization

Clinical Features:

II/4 85y goiter overt hyperthyroidism

Treatment:

default

Functional Characteristics:

cAMP
(basal)

cAMP
(TSH)

IP
(basal)

IP
(TSH)

TSH-Binding

Cell Surface Expression

Prevalence

LRA

Ref

Legend:

cAMP (basal): basal in vitro cAMP production of mutant over wild-type TSHR

cAMP (TSH): maximal in vitro cAMP production of mutant over wild-type TSHR

IP (basal): basal in vitro IP production of mutant over wild-type TSHR

IP (TSH): maximal in vitro IP production of mutant over wild-type TSHR

TSH-binding: maximal TSH-binding compared to the wild-type TSHR

Cell surface expression: cell surface expression of mutant compared to WT-TSHR

LRA: linear regression analysis (LRA) of constitutive activity as a function of TSHR expression determined by 125I-bTSH binding or FACS analysis compared to the wild-type TSHR

Prevalence: Prevalence of (somatic and germline) activating mutations*

Ref: Reference for functional characterization

Child: Found in children.

Reference 1:

Nishihara, Eijun, et al.

Thyroid

Prevalence of thyrotropin receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-thyrotropin receptor antibodies.

2014

Abstract In Medline Available